Delivery Order SPE2DB22D2206-SPE2DB24FHD11

Award Date 5/10/24
Potential Completion Date 5/13/24
Potential Value $6.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. The order is for the pharmaceutical product JANUMET XR 50-1,000 MG TABLET 180S, with a ceiling value of $2,874.61 and a completion date of July 15, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen, a major...
This federal contract award, valued at $5,553.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of JANUMET XR 100-1,000 MG TABLET 90S. The contract has a completion date of May 22, 2024 and is structured as a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,490.05 firm fixed-price delivery order contract is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has an ultimate completion date of July 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,577.75, is for the supply of JANUMET XR 50-1,000 mg tablets in quantities of 180s. The contract has an ultimate completion date of December 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $3,499.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, with a completion date of June 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Janumet XR 50-1,000 mg tablets. The $1,200.22 firm-fixed price delivery order has a completion date of May 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,184.74 firm-fixed-price delivery order is for the supply of JANUMET XR 50-1,000 MG tablets. The contract has an ultimate completion date of September 26, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract has a ceiling value of $1,698.66 and is a Delivery Order with a Firm Fixed Price pricing type. It is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $107,585.26, is for the supply of JANUMET XR 50-1,000 MG tablets. It is a firm fixed-price delivery order contract with a period of performance through November 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,375.98, is a delivery order for JANUMET XR 100-1,000 MG TABLET 90S. The contract is a firm fixed-price arrangement with a completion date of February 23, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHD11
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product JANUMET XR 50-1,000 MG TABLET 180S, with a ceiling value of $6,617.26 and a completion date of May 13, 2024.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

In addition to the DLA IDC, Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. As a major pharmaceutical distribution company, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts for essential medical commodities.

Generated 8/9/24, 9:26 AM